{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:41:03Z","timestamp":1770644463886,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ymgme.2021.09.001","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T11:45:10Z","timestamp":1631706310000},"page":"20-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Health care practitioners' experience-based opinions on providing care after a positive newborn screen for Pompe disease"],"prefix":"10.1016","volume":"134","author":[{"given":"Laura","family":"Davids","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene\u00e9 H.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Lisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Wittenauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgme.2021.09.001_bb0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10545-011-9435-0","article-title":"Newborn screening for lysosomal storage diseases: an ethical and policy analysis","volume":"35","author":"Ross","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0010","series-title":"Principles and Practice of Screening for Disease","first-page":"26","volume":"34","author":"Wilson","year":"1968"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2021.09.001_bb0015","first-page":"1S","article-title":"Newborn screening: toward a uniform screening panel and system","volume":"8 Suppl. 1","year":"2006","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2021.09.001_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.001_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2016.12.004","article-title":"The emerging phenotype of late-onset pompe disease: a systematic literature review","volume":"120","author":"Chan","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"11","key":"10.1016\/j.ymgme.2021.09.001_bb0030","article-title":"Lessons learned from Pompe disease newborn screening and follow-up","volume":"6","author":"Klug","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2015.10.078","article-title":"Very early treatment for infantile-onset pompe disease contributes to better outcomes","volume":"169","author":"Yang","year":"2016","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2021.09.001_bb0040","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","article-title":"Pompe disease: from basic science to therapy","volume":"15","author":"Kohler","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.ymgme.2021.09.001_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ijns6040089","article-title":"Newborn screening for Pompe disease: Pennsylvania experience","volume":"6","author":"Ficicioglu","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"issue":"2","key":"10.1016\/j.ymgme.2021.09.001_bb0050","article-title":"Two-tiered newborn screening with post-analytical tools for Pompe disease and Mucopolysaccharidosis Type 1 results in performance improvement and future direction","volume":"6","author":"Hall","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"issue":"9","key":"10.1016\/j.ymgme.2021.09.001_bb0055","article-title":"The first year experience of newborn screening for Pompe disease in California","volume":"6","author":"Tang","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0060","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1542\/peds.2016-0280C","article-title":"Newborn screening for Pompe disease","volume":"140","author":"Bodamer","year":"2017","journal-title":"Pediatrics"},{"issue":"S1","key":"10.1016\/j.ymgme.2021.09.001_bb0065","article-title":"The initial evaluation of patients after positive newborn screening: recommended algorithms leading to confirmed diagnosis of Pompe disease","volume":"140","author":"Burton","year":"2017","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.001_bb0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2013.08.005","article-title":"Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies","volume":"110","author":"Preisler","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2021.09.001_bb0075","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/mus.23643","article-title":"Pompe disease, the must-not-miss diagnosis: a report of 3 patients","volume":"47","author":"Dubrovsky","year":"2013","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.ymgme.2021.09.001_bb0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/mus.22296","article-title":"How common is misdiagnosis in late-onset Pompe disease?","volume":"45","author":"Hobson-Webb","year":"2012","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.001_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijns4030023","article-title":"Newborn screening for lysosomal storage diseases: methodologies, screen positive rates, normalization of datasets, second-tier tests, and post-analysis tools","volume":"4","author":"Gelb","year":"2018","journal-title":"Int. J. Neonatal Screen."},{"issue":"2","key":"10.1016\/j.ymgme.2021.09.001_bb0090","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10897-015-9879-8","article-title":"Newborn screening for lysosomal storage disorders: views of genetic healthcare providers","volume":"25","author":"Lisi","year":"2015","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2016.07.009","article-title":"Patient's perspectives on newborn screening for later-onset lysosomal storage diseases","volume":"119","author":"Lisi","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2021.09.001_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2431-14-203","article-title":"Newborn screening for Pompe disease? A qualitative study exploring professional views","volume":"14","author":"van El","year":"2014","journal-title":"BMC Pediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2021.09.001_bb0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/WCO.0b013e32834a1e00","article-title":"Challenges in diagnosis and treatment of late-onset Pompe disease","volume":"24","author":"Desnuelle","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijns6010001","article-title":"Is newborn screening the ultimate strategy to reduce diagnostic delays in Pompe disease? The parent and patient perspective","volume":"6","author":"Saich","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"issue":"s1","key":"10.1016\/j.ymgme.2021.09.001_bb0115","article-title":"The role of genetic counseling in pompe disease after patients are identified through newborn screening","volume":"140","author":"Atherton","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2021.09.001_bb0120","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1007\/s00431-003-1355-z","article-title":"Ethical issues in newborn screening and the impact of new technologies","volume":"Suppl","author":"Wilcken","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-genom-090711-163741","article-title":"Ethical issues with newborn screening in the genomics era","volume":"13","author":"Tarini","year":"2012","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pediatrneurol.2017.08.012","article-title":"A historical and current review of newborn screening for neuromuscular disorders from around the world: lessons for the United States","volume":"11","author":"Ross","year":"2017","journal-title":"Pediatr. Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2021.09.001_bb0135","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10545-018-0159-2","article-title":"Newborn screening for Pompe disease: impact on families","volume":"41","author":"Pruniski","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"issue":"8","key":"10.1016\/j.ymgme.2021.09.001_bb0140","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/jamaneurol.2019.1206","article-title":"Maximizing the benefit of life-saving treatments for Pompe disease, spinal muscular atrophy, and Duchenne muscular dystrophy through newborn screening: essential steps","volume":"76","author":"Baker","year":"2019","journal-title":"JAMA Neurol."},{"issue":"31","key":"10.1016\/j.ymgme.2021.09.001_bb0145","article-title":"Newborn screening for Pompe disease","volume":"6","author":"Sawada","year":"2021","journal-title":"Int. J. Neonatal Screen."},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.001_bb0150","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41436-018-0129-y","article-title":"The New York pilot newborn screening program for lysosomal storage diseases: report of the first 65,000 infants","volume":"21","author":"Wasserstein","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0155","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpeds.2017.06.048","article-title":"Newborn screening for lysosomal storage disorders in Illinois: the initial 15-month experience","volume":"190","author":"Burton","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-0036-1593843","article-title":"Newborn screening for lysosomal storage disorders","volume":"6","author":"Peake","year":"2017","journal-title":"J. Pediatr. Genet."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0165","series-title":"Screened Conditions Report","year":"2018"},{"issue":"4","key":"10.1016\/j.ymgme.2021.09.001_bb0170","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/0022146510386794","article-title":"Patients-in-waiting: living between sickness and health in the genomics era","volume":"51","author":"Timmermans","year":"2010","journal-title":"J. Health Soc. Behav."},{"issue":"22","key":"10.1016\/j.ymgme.2021.09.001_bb0175","article-title":"A newborn screening, presymptomatically identified infant with late-onset Pompe disease: case report, parental experience, and recommendations","volume":"6","author":"Wang","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0180","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ebiom.2019.03.048","article-title":"A genetic modifier of symptom onset in Pompe disease","volume":"43","author":"Bergsma","year":"2019","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.ymgme.2021.09.001_bb0185","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s10038-019-0603-7","article-title":"Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients","volume":"64","author":"Momosaki","year":"2019","journal-title":"J. Hum. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2021.09.001_bb0190","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1542\/peds.2016-0280E","article-title":"Management of confirmed newborn-screened patients with Pompe disease across the disease spectrum","volume":"140","author":"Kronn","year":"2017","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ymgme.2021.09.001_bb0195","first-page":"S1","article-title":"Prospective chart review of the management of late-onset Pompe patients diagnosed through newborn screening. [abstract taken from Molecular Genetics and Metabolism. 2020;129(2):S1]","volume":"129","author":"Horgan","year":"2020","journal-title":"Mol. Genet. Metabol."},{"issue":"15","key":"10.1016\/j.ymgme.2021.09.001_bb0200","article-title":"Public support for neonatal screening for Pompe disease, a broad-phenotype condition","volume":"7","author":"Weinreich","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.001_bb0205","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ymgme.2012.08.008","article-title":"Experiences of parents and patients with the timing of Mucopolysaccharidosis type I (MPS I) diagnoses and its relevance to the ethical debate on newborn screening","volume":"107","author":"de Ru","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2021.09.001_bb0210","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.21037\/jtd.2017.05.34","article-title":"A general introduction to adjustment for multiple comparisons","volume":"9","author":"Chen","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2021.09.001_bb0215","article-title":"Newborn screening for pompe disease in Illinois: experience with 684,290 infants","volume":"6","author":"Burton","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"issue":"6","key":"10.1016\/j.ymgme.2021.09.001_bb0220","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1212\/WNL.0b013e318228c15f","article-title":"\u201cI'm fine; I'm just waiting for my disease\u201d: the new and growing class of presymptomatic patients","volume":"77","author":"Kwon","year":"2011","journal-title":"Neurology"},{"issue":"48","key":"10.1016\/j.ymgme.2021.09.001_bb0225","article-title":"Expanding newborn screening for Pompe disease in the United States: the NewSTEPs New Disorders Implementation Project, a resource for new disorder implementation","volume":"6","author":"Hale","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0230","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency","author":"Hirschhorn","year":"2001"},{"key":"10.1016\/j.ymgme.2021.09.001_bb0235","article-title":"Inequities in newborn screening: race and the role of medicaid","volume":"9","author":"Sohn","year":"2019","journal-title":"SSM Popul. Health"},{"issue":"7","key":"10.1016\/j.ymgme.2021.09.001_bb0240","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ejhg.2010.13","article-title":"Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening","volume":"18","author":"Bombard","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2021.09.001_bb0245","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/ejhg.2011.188","article-title":"Health-care providers' views on pursuing reproductive benefit through newborn screening: the case of sickle cell disorders","volume":"20","author":"Bombard","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.09.001_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.childyouth.2020.105518","article-title":"Inclusion and equity in educational services for children with rare diseases: challenges and opportunities","volume":"119","author":"Verger","year":"2020","journal-title":"Child Youth Serv. Rev."},{"issue":"1-2","key":"10.1016\/j.ymgme.2021.09.001_bb0260","first-page":"109","article-title":"Opinions of adults affected with later-onset lysosomal storage diseases regarding newborn screening: a qualitative study","volume":"119","author":"Lisi","year":"2021","journal-title":"J. Genet. Couns."},{"issue":"9","key":"10.1016\/j.ymgme.2021.09.001_bb0265","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.gim.0000237790.54074.3d","article-title":"Exploring barriers to long-term follow-up in newborn screening programs","volume":"8","author":"Hoff","year":"2006","journal-title":"Genet Med."},{"issue":"2","key":"10.1016\/j.ymgme.2021.09.001_bb0270","first-page":"S1","article-title":"Reducing false positives in newborn screening for lysosomal storage disorders. [abstract taken from Molecular Genetics and Metabolism. 2020;129(2):S1]","volume":"129","author":"Washburn","year":"2020","journal-title":"Mol. Genet. Metabol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:51:40Z","timestamp":1761090700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221007770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":53,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1096719221007770"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.09.001","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health care practitioners' experience-based opinions on providing care after a positive newborn screen for Pompe disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}